Zofran Birth Defect MDL Finally Heading For Trial In Fall
A Massachusetts federal judge running the first bellwether in multidistrict litigation over whether GlaxoSmithKline's anti-nausea medication Zofran causes birth defects said Wednesday that he's considering an October starting date after a...To view the full article, register now.
Already a subscriber? Click here to view full article